Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunomodulation by opioid peptidomimetic compound.

P Narayan1, V K Singh, S S Agarwal

  • 1Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India.

Neuroimmunomodulation
|December 26, 2001
PubMed
Summary

Synthetic compound 3 demonstrates significant immunosuppressive potential by inhibiting mixed lymphocyte reactions and cell proliferation. Its effects are mediated via mu-opioid receptors, offering new avenues for immunomodulatory therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Author Correction: Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Universal DNA methylation age across mammalian tissues.

Nature aging·2023
Same author

Corrigendum to "Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria": [Annals of Oncology 32 (2021) 950-953].

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Bringing safe and effective therapies to premenopausal women with breast cancer: efforts to broaden eligibility criteria.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

Area of Science:

  • Immunology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Opioid peptides have known immunomodulatory effects.
  • Previous studies explored immunomodulation with opioid peptides.
  • This research focuses on novel synthetic peptidomimetics.

Purpose of the Study:

  • Synthesize and evaluate four novel peptidomimetic compounds.
  • Assess the immunomodulatory activity of these compounds in vitro.
  • Investigate the mechanism of action for potential immunosuppressive agents.

Main Methods:

  • Compounds synthesized via solution phase chemistry.
  • Immunomodulatory activity assessed using mixed lymphocyte reaction (MLR).
  • Cell proliferation, TNF-alpha, and nitric oxide production were measured.

Related Experiment Videos

Main Results:

  • Compound 3 exhibited significant immunosuppressive properties.
  • Compound 3 inhibited two-way MLR and proliferation of mu-opioid receptor-expressing cells.
  • Inhibition was reversed by opioid receptor antagonists, indicating mu-opioid receptor involvement.

Conclusions:

  • Compound 3 effectively suppresses immune responses in vitro.
  • The mechanism of action involves interaction with mu-opioid receptors.
  • These findings suggest potential therapeutic applications for compound 3 in immune modulation.